Effects of Increased Arterial Epinephrine on Insulin, Glucose and Phosphate

References

• Pollare T, Lithell H, Berne C. Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism 1990; 39: 167–74
   PubMed Web of Science ®Google Scholar
• Ferranini E, Buzzigoli G, Bonadonna R. Insulin resistance in essential hypertension. N Engl J Med 1987; 317: 350–7
   PubMed Web of Science ®Google Scholar
• DeFronzo RA. Insulin resistance: the metabolic link between non-insulin-dependent diabetes mellitus, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Curr Opin Cardiol 1990; 5: 586–93
   Web of Science ®Google Scholar
• Reaven GM. Insulin resistance and compensatory hyperinsulinemia: Role in hypertension, dyslipidemia, and coronary heart disease. Am Heart J 1991; 121: 1283–9
   PubMed Web of Science ®Google Scholar
• Rocchini AP. Insulin resistance and blood pressure regulation in obese and nonobese subjects. Hypertension 1991; 17: 837–42
   PubMed Web of Science ®Google Scholar
• Franco-Morselli R, Elghozi JL, Joly E, Di Giuilio S, Meyer P. Increased plasma adrenaline concentrations in benign essential hypertension. BMJ 1977; 2: 1251–4
   PubMed Web of Science ®Google Scholar
• Goldstein DS. Plasma catecholamines and essential hypertension. An analytical review. Hypertension 1983; 5: 86–99
   PubMed Web of Science ®Google Scholar
• Kjeldsen SE, Zweifler AJ, Petrin J, Weder AB, Julius S. Sympathetic nervous system involvement in essential hypertension: increased platelet noradrenaline coincides with decreased beta-adrenoreceptor responsiveness. Blood Pressure 1994; 3: 164–71
   PubMedGoogle Scholar
• Sherwin RS, Saccà L. Effect of epinephrine on glucose metabolism in humans: contributions of the liver. Am J Physiol 1984; 247: E157–65
   PubMed Web of Science ®Google Scholar
• Rizza R, Haymond M, Cryer P, Gerich J. Differential effects of epinephrine on glucose production and disposal in man. Am J Physiol 1979; 237: E356–62
   PubMedGoogle Scholar
• Saccà L, Morrone G, Cicala M. Influence of epinephrine, norepinephrine and isoproterenol on glucose homeostasis in normal man. J Clin Endocrin Metab 1980; 50: 680–4
   PubMed Web of Science ®Google Scholar
• Julius S, Gudbrandsson T, Jamerson K, Tariq Shahab S, Anderson O. The hemodynamic link between insulin resistance and hypertension. J Hypertens 1991; 9: 983–6
   PubMed Web of Science ®Google Scholar
• Peuler JD, Johnson GA. Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. Life Sci. 1977; 21: 625–36
   PubMed Web of Science ®Google Scholar
• Saccà L, Vigorito C, Cicala M. Mechanisms of epinephrine induced glucose intolerance in normal humans. J Clin Invest 1982; 69: 284–93
   PubMed Web of Science ®Google Scholar
• Deibert DC, DeFronzo RA. Epinephrine-induced insulin resistance in man. J Clin Invest 1980; 65: 717–21
   PubMed Web of Science ®Google Scholar
• DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214–23
   PubMed Web of Science ®Google Scholar
• Hamburg S, Hendler R, Sherwin RS. Influence of small increments of epinephrine on glucose tolerance in normal humans. Ann Intern Med 1980; 93: 566–8
   PubMed Web of Science ®Google Scholar
• Rostrup M, Mundal HH, Westheim A, Eide I. Awareness of high blood pressure increases arterial plasma catecholamines, platelet noradrenaline and adrenergic responses to mental stress. J Hypertens 1991; 9: 159–66
   PubMed Web of Science ®Google Scholar
• Porte D, Jr. A receptor mechanism for the inhibition of insulin release by epinephrine in man. J Clin Invest 1967; 46: 86–94
   PubMed Web of Science ®Google Scholar
• Clutter WE, Bier DM, Shah SD, Cryer PE. Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic action in man. J Clin Invest 1980; 66: 94–101
   PubMed Web of Science ®Google Scholar
• Staten MA, Mattews DE, Cryer PE, Bier DM. Physiological increments in epinephrine metabolic rate in humans. Am J Physiol 1987; 253: E322–30
   Google Scholar
• Kjeldsen SE, Rostrup M, Moan A, Mundal HH, Gjesdal K, Eide IK. The sympathetic nervous system may modulate the metabolic cardiovascular syndrome in essential hypertension. J Cardiovasc Pharmacol 1992; 20: S32–9, (Suppl 8)
   Google Scholar
• Kjeldsen SE, Westheim A, Aakesson I, Eide I, Leren P. Plasma adrenaline and noradrenaline during orthostasis in man: the importance of arterial sampling. Scand J Clin Lab Invest 1986; 46: 397–401
   PubMed Web of Science ®Google Scholar
• Body J-J, Cryer PE, Offord KP, Heath H. Epinephrine is a hypophosphatemic hormone in man. J Clin Invest 1983; 71: 572–8
   PubMedGoogle Scholar
• Ljunghall S, Joborn H, Rastad J, Akerstrøm G. Plasma potassium and phosphate concentrations—Influence by adrenaline infusion, p-blockade and physical exercise. Acta Med Scand 1987; 221: 83–93
   PubMedGoogle Scholar
• Kjeldsen SE, Os I, Westheim A. Decreased serum phosphate in essential hypertension. Related to increased sympathetic tone. Am J Hypertens 1988; 1: 403–9
   PubMed Web of Science ®Google Scholar
• McCarron D, Pingree PA, Rubin RJ. Enhanced parathyroid function in essential hypertension: a homeostatic response to a urinary calcium leak. Hypertension 1980; 2: 162–8
   PubMed Web of Science ®Google Scholar
• Uza G, Olimpia P, Agotha K. Serum concentrations of Na, K, Ca, Mg, P, Zn and Cu in patients with essential arterial hypertension. Clin Exp Hypertens 1984; A6: 1415–29
   Google Scholar
• Allan FN, Dickson BR, Markowitz J. The relationship of phosphate and carbohydrate metabolism. II. The effect of adrenaline and phlorridzin on the excretion of phosphate. Am J Physiol 1925; 70: 333–43
   Google Scholar
• Richter EA, Ruderman NB, Galbo H. Alpha and beta adrenergic effects on metabolism in contracting, perfused muscle. Acta Physiol Scand 1982; 116: 215–22
   PubMedGoogle Scholar
• Chasiotis D, Sahlin K, Hultman E. Regulation of glycogenolysis in human muscle in response to epinephrine infusion. J Appl Physiol 1983; 54: 45–50
   PubMed Web of Science ®Google Scholar
• Huang W-H, Askari A. Regulation of (Na + K +)-ATPase by inorganic phosphate: pH dependence and physiological implications. Biochem Biophys Res Commun 1984; 123: 438–43
   PubMed Web of Science ®Google Scholar
• Gudmundsson O, Herlitz H, Jonsson O. Blood pressure and intra-erythrocyte sodium during normal and high salt intake in middle-aged men: Relationship to family history of hypertension, and neurogenic and hormonal variables. Clin Sci 1984; 66: 427–33
   PubMed Web of Science ®Google Scholar